OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nonalcoholic fatty liver disease
Elizabeth M. Brunt, Vincent Wai‐Sun Wong, Valério Nobili, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 713
Elizabeth M. Brunt, Vincent Wai‐Sun Wong, Valério Nobili, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 713
Showing 1-25 of 713 citing articles:
Cellular senescence drives age-dependent hepatic steatosis
Mikołaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 836
Mikołaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 836
Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 743
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 743
Senolytic CAR T cells reverse senescence-associated pathologies
Corina Amor, Judith Feucht, Josef Leibold, et al.
Nature (2020) Vol. 583, Iss. 7814, pp. 127-132
Open Access | Times Cited: 740
Corina Amor, Judith Feucht, Josef Leibold, et al.
Nature (2020) Vol. 583, Iss. 7814, pp. 127-132
Open Access | Times Cited: 740
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab, Marco Arrese, Michael Trauner
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 321-350
Open Access | Times Cited: 480
Juan Pablo Arab, Marco Arrese, Michael Trauner
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 321-350
Open Access | Times Cited: 480
Non-alcoholic fatty liver disease
Brent A. Neuschwander‐Tetri
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 411
Brent A. Neuschwander‐Tetri
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 411
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Nature Medicine (2019) Vol. 25, Iss. 4, pp. 641-655
Open Access | Times Cited: 318
Mohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Nature Medicine (2019) Vol. 25, Iss. 4, pp. 641-655
Open Access | Times Cited: 318
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
Carlotta Giorgi, Saverio Marchi, Inês C. M. Simões, et al.
International review of cell and molecular biology (2018), pp. 209-344
Open Access | Times Cited: 317
Carlotta Giorgi, Saverio Marchi, Inês C. M. Simões, et al.
International review of cell and molecular biology (2018), pp. 209-344
Open Access | Times Cited: 317
Role of inflammatory response in liver diseases: Therapeutic strategies
J.A. Del Campo, Paloma Gallego, Lourdes Grande
World Journal of Hepatology (2018) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 302
J.A. Del Campo, Paloma Gallego, Lourdes Grande
World Journal of Hepatology (2018) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 302
PPARs and nonalcoholic fatty liver disease
Kim Liss, Brian N. Finck
Biochimie (2016) Vol. 136, pp. 65-74
Open Access | Times Cited: 262
Kim Liss, Brian N. Finck
Biochimie (2016) Vol. 136, pp. 65-74
Open Access | Times Cited: 262
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Ruth Chan, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 6, pp. 1349-1356
Closed Access | Times Cited: 254
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Ruth Chan, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 6, pp. 1349-1356
Closed Access | Times Cited: 254
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology (2017) Vol. 23, Iss. 1, pp. 1-12
Open Access | Times Cited: 200
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology (2017) Vol. 23, Iss. 1, pp. 1-12
Open Access | Times Cited: 200
Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients
Silvia Sookoian, Carlos J. Pirola
Alimentary Pharmacology & Therapeutics (2017) Vol. 46, Iss. 2, pp. 85-95
Open Access | Times Cited: 197
Silvia Sookoian, Carlos J. Pirola
Alimentary Pharmacology & Therapeutics (2017) Vol. 46, Iss. 2, pp. 85-95
Open Access | Times Cited: 197
Pathogenesis and novel treatment options for non-alcoholic steatohepatitis
Vincent Wai‐Sun Wong, Shivakumar Chitturi, Grace Lai‐Hung Wong, et al.
The Lancet. Gastroenterology & hepatology (2016) Vol. 1, Iss. 1, pp. 56-67
Closed Access | Times Cited: 174
Vincent Wai‐Sun Wong, Shivakumar Chitturi, Grace Lai‐Hung Wong, et al.
The Lancet. Gastroenterology & hepatology (2016) Vol. 1, Iss. 1, pp. 56-67
Closed Access | Times Cited: 174
Health benefits of fucoxanthin in the prevention of chronic diseases
Minkyung Bae, Mi-Bo Kim, Young‐Ki Park, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1865, Iss. 11, pp. 158618-158618
Closed Access | Times Cited: 166
Minkyung Bae, Mi-Bo Kim, Young‐Ki Park, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1865, Iss. 11, pp. 158618-158618
Closed Access | Times Cited: 166
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
Chander K. Negi, Pavel Babica, Lola Bajard, et al.
Metabolism (2021) Vol. 126, pp. 154925-154925
Open Access | Times Cited: 163
Chander K. Negi, Pavel Babica, Lola Bajard, et al.
Metabolism (2021) Vol. 126, pp. 154925-154925
Open Access | Times Cited: 163
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen Heyens, Dana Busschots, Ger H. Koek, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 162
Leen Heyens, Dana Busschots, Ger H. Koek, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 162
Treatments for NAFLD: State of Art
Alessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2350-2350
Open Access | Times Cited: 161
Alessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2350-2350
Open Access | Times Cited: 161
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Silvia Sookoian, Adrián Salatino, Gustavo Castaño, et al.
Gut (2020) Vol. 69, Iss. 8, pp. 1483-1491
Open Access | Times Cited: 157
Silvia Sookoian, Adrián Salatino, Gustavo Castaño, et al.
Gut (2020) Vol. 69, Iss. 8, pp. 1483-1491
Open Access | Times Cited: 157
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
Tea Lund Laursen, Christoffer Hagemann, Chunshan Wei, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 2, pp. 138-149
Open Access | Times Cited: 155
Tea Lund Laursen, Christoffer Hagemann, Chunshan Wei, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 2, pp. 138-149
Open Access | Times Cited: 155
Brown Adipose Crosstalk in Tissue Plasticity and Human Metabolism
Camilla Schéele, Christian Wolfrum
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 53-65
Open Access | Times Cited: 153
Camilla Schéele, Christian Wolfrum
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 53-65
Open Access | Times Cited: 153
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1043-1054
Open Access | Times Cited: 144
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1043-1054
Open Access | Times Cited: 144
CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
Yuzo Koda, Toshiaki Teratani, Po–Sung Chu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 134
Yuzo Koda, Toshiaki Teratani, Po–Sung Chu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 134
Activity-based fluorescence probes for pathophysiological peroxynitrite fluxes
Zhiqiang Mao, Jianhua Xiong, Pengzhan Wang, et al.
Coordination Chemistry Reviews (2021) Vol. 454, pp. 214356-214356
Closed Access | Times Cited: 126
Zhiqiang Mao, Jianhua Xiong, Pengzhan Wang, et al.
Coordination Chemistry Reviews (2021) Vol. 454, pp. 214356-214356
Closed Access | Times Cited: 126
Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study
Shuai Yuan, Jie Chen, Xue Li, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 7, pp. 723-733
Open Access | Times Cited: 124
Shuai Yuan, Jie Chen, Xue Li, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 7, pp. 723-733
Open Access | Times Cited: 124
Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 104
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 104
